Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and ...

The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.

Isolation and treatment facilities had to be built, mobile laboratories set up and local laboratory technicians trained to test samples and confirm cases of Ebola. For the vaccine to be effective ...

Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and safety. To address this challenge, researchers have developed the first ...

One potential short-term solution to the coronavirus crisis is remdesivir, an experimental antiviral drug that was previously tested as a treatment for Ebola. The antiviral was developed by Gilead ...

Ebola is generally known to spread through contact with bodily fluids from individuals who have the infection.

An antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering hope that the same approach could be used to combat COVID-19.

The discovery will give researchers around the world the ability to study potential new treatments against Ebola without having to work in an extreme biosafety lab. Disclaimer: AAAS and EurekAlert!

More than 40 years after it was identified, the Ebola virus continues to defy drugs, treatment plans—and experts’ best efforts to solve its mysteries. Ebola vaccine has to be kept cold.

A groundbreaking study has unveiled how the Ebola virus can traverse through layers of human skin, potentially facilitating direct transmission through touch. This highlights critical cellular targets ...

Ebola virus, causing outbreaks of fatal infection ... particles (PCR test), or to measure immune responses (antibodies). Treatments can help manage condition, no known cure Diagnosed by medical ...